The Alliance for Clinical Trials in Oncology has named new investigators to leadership roles across its Immuno-Oncology, Radiation Oncology, and Imaging Committees. These accomplished leaders bring expertise spanning immunotherapy, breast, and brain cancers, precision radiotherapy, and advanced imaging technologies.
The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research, and training
